CD8A and rheumatoid arthritis: We observed that participants with RA on various classes of immunomodulatory drugs mounted spike-specific CD8+ T cell responses that were comparable to those found in non-RA controls, similar to what has been previously reported in participants with RA and controls after the third SARS-CoV-2 vaccination22.